Pharma Mergers and Acquisitions
Add bookmarkDespite the volume of deals dipping, pharma companies paid a lot more for mergers and acquisitions in 2016. The FT reports that the value of deals increased by almost double.
Despite the volume of deals dipping, pharma companies paid a lot more for mergers and acquisitions in 2016. The FT reports that the value of deals increased by almost double.